T2 Biosystems Statistics
T2 Biosystems (0A57) Stock Statistics & Valuation Metrics
Total Valuation
T2 Biosystems has a market cap or net worth of $252.41K. The enterprise value is $52.11M.
- Market Cap
- $252.41K
- Enterprise Value
- $52.11M
Share Statistics
T2 Biosystems has 28,045,418 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 28,045,418
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
T2 Biosystems’s return on equity (ROE) is 1.79 and return on invested capital (ROIC) is -230.51%.
- Return on Equity (ROE)
- 1.79
- Return on Assets (ROA)
- -1.44
- Return on Invested Capital (ROIC)
- -230.51%
- Return on Capital Employed (ROCE)
- 2.33
- Revenue Per Employee
- 63.65K
- Profits Per Employee
- -443.16K
- Employee Count
- 113
- Asset Turnover
- 0.21
- Inventory Turnover
- 3.19
Valuation Ratios
The current PE Ratio of T2 Biosystems is -0.00. T2 Biosystems’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.04
- PB Ratio
- -0.00
- Price to FCF
- -0.01
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, T2 Biosystems had revenue of 7.19M and earned -50.08M in profits. Earnings per share was -19.19.
- Revenue
- 7.19M
- Gross Profit
- -8.17M
- Operating Income
- -49.66M
- Pretax Income
- -50.08M
- Net Income
- -50.08M
- EBITDA
- -43.88M
- Earnings Per Share (EPS)
- -19.19
Cash Flow
In the last 12 months, operating cash flow was -36.59M and capital expenditures -26,000, giving a free cash flow of -36.62M billion.
- Operating Cash Flow
- -36.59M
- Free Cash Flow
- -36.62M
- Free Cash Flow per Share
- -18.52
Dividends & Yields
T2 Biosystems pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -17232.06%
- Earnings Yield
- -191867.08%
Stock Price Statistics
- Beta
- 0.57
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.15
- 200-Day Moving Average
- 0.15
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
T2 Biosystems upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Mar 04, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
T2 Biosystems as a current ratio of 0.45, with Debt / Equity ratio of -176.55%
- Current Ratio
- 0.45
- Quick Ratio
- 0.36
- Debt to Market Cap
- 2.52
- Net Debt to EBITDA
- -0.77
- Interest Coverage Ratio
- -9.30
Taxes
In the past 12 months, T2 Biosystems has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
T2 Biosystems EV to EBITDA ratio is -0.78, with an EV/FCF ratio of -0.71.
- EV to Sales
- 4.74
- EV to EBITDA
- -0.78
- EV to Free Cash Flow
- -0.71
- EV to Operating Cash Flow
- -0.71
Balance Sheet
T2 Biosystems has $2.08M in cash and marketable securities with $18.94M in debt, giving a net cash position of -$16.86M billion.
- Cash & Marketable Securities
- $2.08M
- Total Debt
- $18.94M
- Net Cash
- -$16.86M
- Net Cash Per Share
- -$0.60
- Tangible Book Value Per Share
- -$0.65
Margins
Gross margin is -113.58%, with operating margin of -690.45%, and net profit margin of -696.19%.
- Gross Margin
- -113.58%
- Operating Margin
- -690.45%
- Pretax Margin
- -696.19%
- Net Profit Margin
- -696.19%
- EBITDA Margin
- -609.97%
- EBIT Margin
- -621.91%
